Evaluation of a new PCR assay with competitive internal control sequence for blood donor screening

Transfusion

Volumn 40, Issue 6, 2000, Pages 718-724

  Drosten, C ^a   Weber, M ^a   Seifried, E ^a   Roth, W K ^a,b  

^a Inst Transfus Med I   (Germany)

^b Inst F Transfusionsmedizin I   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; BLOOD DONOR; CONTROL; GENE AMPLIFICATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SCREENING; SEROCONVERSION; SITE DIRECTED MUTAGENESIS;

BLOOD DONORS; DNA, VIRAL; EVALUATION STUDIES; GENOME, VIRAL; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VIRUS; HUMANS; MASS SCREENING; POLYMERASE CHAIN REACTION; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; SEQUENCE ALIGNMENT; TIME FACTORS; VIREMIA;

EID: 0034086777     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2000.40060718.x     Document Type: Article

References (20)

1. Caspari G, Gerlich WH. High sensitive detection of virus genomes in transfusion medicine. Infusionsther Transfusionsmed 1998;25:74-81.
2. Jongerius JM, Wester M, Cuyper HTM, et al. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion 1998;38:56-9.
3. Thiers, V, Nakajima E, Kremsdort D, et al. Transmission of hepatitis B from hepatitis B-seronegative subjects. Lancet 1988; Dec. 1988,2:1273-6.
4. Schreiber GB, Busch MP, Kleinmann SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Study. N Engl J Med 1996;334:1685-90.
5. Ortiz A, Ritter E. A rapid method for detecting specific amplified PCR fragments in microtiter plates. Nucleic Acids Res 1996;24:3280-1.
6. Vogel JU, Cinatl J, Lux A, et al. New PCR assay for rapid and quantitative detection of human cytomegalovirus in cerebrospinal fluid. J Clin Microbiol 1996;34:482-3.
7. Von Förster, Th. Zwischenmolekulare Energiewanderung und Fluoreszenz. (Engl abstract not available) Ann Phys (Leipzig) 1948;2:55-7.
8. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′ to 3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci U S A 1991;88:7276-80.
9. Livak KJ, Flood SJ, Marmaro J, et al. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybidization. PCR Methods Appl 1995;4:357-62.
10. Cone RW, Hobson AC, Huang ML. Coamplified positive control detects inhibition of polymerase chain reaction. J Clin Microbiol 1992;30:3185-9.
11. Kox LF, Rhienthong D, Miranda AM, et al. A more reliable PCR for detection of mycobacterium tuberculosis in clinical samples. J Clin Microbiol 1994;32:672-8.
12. Rosenstraus M, Wang Z, Chang SY, et al. An internal control for routine diagnostic PCR: design, properties, and effect on clinical performance. J Clin Microbiol 1998;36:191-7.
13. Galibert F, Mandart E, Fituossi F, et al. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 1979;281:646-50.
14. Higuchi R. Using PCR to engineer DNA. In: Ehrlich HA, ed. PCR technology: principles and applications for DNA amplification. New York: Stockton Press, 1989:63-9.
15. Rüster B, Zeuzem S, Roth WK. Quantification of hepatitis C virus RNA, by competitive reverse transcription and polymerase chain reaction using a modified hepatitis C virus RNA transcript. Anal Biochem 1995;224:597-600.
16. Roth WK, Weber M, Seifried E. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood bank setting. Lancet 1999;353:359-63.
17. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989;339:237-8.
18. Bliss CI. The calculation of the dosage-mortality curve. Ann Appl Biol 1935;22:134-67.
19. Finney DJ. Probit analysis. 3rd ed. London: Cambridge University Press, 1971.
20. Nübling CM, Seitz R, Löwer J. Application of nucleic acid amplification techniques for blood donor screening. Infusionsther Transfusionsmed 1998;25:86-90.